About Us
Our Story
Our Mission & Values
Our Team
Leadership
Board of Directors
Scientific Advisory Board
Our Science
What is Gene Therapy
The Taysha Strategy
Pipeline
TSHA-102 in Rett Syndrome
Other Programs
Healthcare Professionals
Clinical Trials
Scientific Posters & Publications
Expanded Access Policy
Patients & Caregivers
Our Guiding Principles
Community Support and Resources
Patient Affairs
Investors
News & Events
Financial Information
Stock Information
Corporate Governance
Shareholder Resources
Careers
Heart of Taysha
Open Positions
Contact
Menu
Menu
Laura Sepp-Lorenzino, Ph.D.
Chief Scientific Officer, Intellia Therapeutics
BACK TO OUR TEAM
Scroll to top
